login
login

Europe Daily Bulletin No. 12847

7 December 2021
Contents Publication in full By article 18 / 27
EU RESPONSE TO COVID-19 / Health
European Medicines Agency recommends use of anti-inflammatory drug RoActemra for Covid-19
Brussels, 06/12/2021 (Agence Europe)

The European Medicines Agency (EMA) recommended on Monday 6 December that the use of the anti-inflammatory drug RoActemra be extended to adult inpatients with severe Covid-19 “already receiving corticosteroid treatment and requiring supplemental oxygen or mechanical ventilation(see EUROPE B12774A8).

This treatment, marketed by the German company Roche Registration GmbH, has been authorised in the EU since 2009 for the treatment of inflammatory diseases such as rheumatoid arthritis and...

Contents

SOCIAL AFFAIRS
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
ECONOMY - FINANCE - BUSINESS
SECTORAL POLICIES
INSTITUTIONAL
SECURITY - DEFENCE
EXTERNAL ACTION
EU RESPONSE TO COVID-19
COUNCIL OF EUROPE
NEWS BRIEFS